Circulating MicroRNAs to Predict Breast Cancer Recurrence Circulating MicroRNAs to Predict Breast Cancer Recurrence
Can plasma microRNA be used to predict breast cancer recurrence years before clinical detection?Breast Cancer Research (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 5, 2018 Category: Consumer Health News Tags: Internal Medicine Journal Article Source Type: news

Kenya:Agony for Children as KNH Cancer Drugs Run Out
[Nairobi News] Cancer drugs for children receiving treatment at the Kenyatta National Hospital have run out, putting the lives of the young ones at risk. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - November 5, 2018 Category: African Health Source Type: news

Women who are 'larks' have a lower risk of developing breast cancer
(National Cancer Research Institute) Women who are 'larks', functioning better at the beginning of the day than the end of the day, have a lower of risk breast cancer, according to new research presented at the 2018 NCRI Cancer Conference on Tuesday. The study looked at several hundred thousand women. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 5, 2018 Category: Cancer & Oncology Source Type: news

Doctors and nurses reluctant to recommend e-cigarettes to cancer patients
(National Cancer Research Institute) Twenty-nine per cent of health professionals would not recommend e-cigarettes to cancer patients who already smoke, according to research presented at the 2018 NCRI Cancer Conference. While e-cigarettes may pose some health risks, evidence suggests they are much less harmful than smoking. Health bodies have given support for the use of e-cigarettes as a less harmful alternative. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 5, 2018 Category: Cancer & Oncology Source Type: news

Gap in research means millions living with long-term consequences of cancer
(National Cancer Research Institute) Millions of people are living with the long-term consequences of cancer and its treatment, but currently there is very little research on the problems they face and how these can be tackled. This growing population report side-effects that seriously affect their quality of life, but a combination of a shortage of funding, a lack of clear direction and relatively few researchers with expertise in this area have left a gap in cancer research. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 5, 2018 Category: Cancer & Oncology Source Type: news

Gut stem cells offer clues for preventing tumours in inherited bowel cancer
(National Cancer Research Institute) Treating pre-cancerous stem cells at an early stage could be key to preventing bowel cancer in people born with a very high risk of the disease, according to a study in mice presented at the 2018 NCRI Cancer Conference. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 5, 2018 Category: Cancer & Oncology Source Type: news

Great honor for research on vehicle emissions
(Swiss Federal Laboratories for Materials Science and Technology (EMPA)) This year's Swiss Aerosol Award goes to Maria Mu ñ oz. The Empa researcher investigated the emission behavior of so-called GDI engines (gasoline-direct injection). Her results are alarming: GDI vehicles emit up to 17 times more carcinogenic substances than modern diesel vehicles. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - November 5, 2018 Category: Biology Source Type: news

Caterpillar, fungus in cahoots to threaten fruit, nut crops, study finds
(University of Illinois at Urbana-Champaign) New research reveals that Aspergillus flavus, a fungus that produces carcinogenic aflatoxins that can contaminate seeds and nuts, has a multilegged partner in crime: the navel orangeworm caterpillar, which targets some of the same nut and fruit orchards afflicted by the fungus. Scientists report in the Journal of Chemical Ecology that the two pests work in concert to overcome plant defenses and resist pesticides. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - November 5, 2018 Category: Biology Source Type: news

Team studying rare disorder discovers novel way to target melanoma
(University of North Texas Health Science Center) While studying a rare genetic disorder called NGLY1 deficiency, UNT Health Science Center researchers discovered a new targeted treatment for combating melanoma, a skin cancer that kills about 9,000 people in the United States each year. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 5, 2018 Category: International Medicine & Public Health Source Type: news

Dana-Farber scientists find new drug targets in aggressive cancers
(Dana-Farber Cancer Institute) Scientists have discovered a previously unknown molecular vulnerability in two rare, aggressive, and hard-to-treat types of cancer, and say it may be possible to attack this weakness with targeted drugs. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 5, 2018 Category: International Medicine & Public Health Source Type: news

Timely care key to improving survival rates and racial disparities
(Medical University of South Carolina) Postoperative radiotherapy is needed within six weeks of surgery in patients with head and neck cancer, but delays are common. Researchers at MUSC and Hollings Cancer Center report that 56 percent of African American patients experienced a delay in care while only 43 percent of white patients did. Small changes to the way that cancer care is delivered can decrease these delays, but more research is needed to pinpoint the exact causes behind it. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 5, 2018 Category: International Medicine & Public Health Source Type: news

Sitting is NOT the new smoking, contrary to popular myth
(University of South Australia) No, sitting is not the new smoking, despite what countless newspaper articles have peddled in recent years. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 5, 2018 Category: Cancer & Oncology Source Type: news

Phobic anxiety is linked to sexuality issues in women who are breast cancer survivors
(University of C ó rdoba) A University of Cordoba research project reveals that mental well-being is a determining factor in sexual dysfunction in women affected by this kind of cancer. Psychological variables are determining factors in sexuality development. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 5, 2018 Category: Cancer & Oncology Source Type: news

First-of-its-kind research models immune responses in cellular immunotherapies
(Virginia Commonwealth University) In the Cellular Immunotherapy and Transplantation Program at Virginia Commonwealth University Massey Cancer Center, scientists are pursuing a cross-collaborative effort that could potentially change the way cellular immunotherapies such as stem cell transplantation and CAR T-cell therapies are performed. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 5, 2018 Category: Cancer & Oncology Source Type: news

Breast cancer cells become invasive by changing their identity
(Karolinska Institutet) Researchers from Karolinska Institutet in Sweden have identified a protein that determines the identity and invasive properties of breast cancer cells. The finding could lead to the development of new therapeutic and diagnostic strategies to target breast cancer invasion and metastasis. The study is published in the scientific journal Cancer Research. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 5, 2018 Category: Cancer & Oncology Source Type: news

Clues for drugging the 'undruggable'
(Friedrich Miescher Institute) Nicolas Thom ä 's group at the Friedrich Miescher Institute for Biomedical Research (FMI) has joined forces with the group of Benjamin Ebert at Harvard's Broad Institute to show how thalidomide analogs mediate degradation of many more proteins than previously anticipated. These proteins -- zinc finger transcription factors -- play a role in cancer and developmental diseases but are difficult drug targets. The new study, published in Science, suggests that thalidomide analogs can be rationally designed to target this challenging class of proteins. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 5, 2018 Category: Cancer & Oncology Source Type: news

Proton therapy for pediatric brain tumors has favorable cognitive outcomes
(Northwestern Memorial HealthCare) Proton therapy treatment for pediatric brain tumor patients is associated with better neurocognitive outcomes compared to x-ray radiation therapy according to a study by Northwestern Medicine. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 5, 2018 Category: Cancer & Oncology Source Type: news

Establishing immunotherapy for pediatric liver cancer
(University of Houston) As part of a $6 million effort to establish new therapies for often-fatal pediatric liver cancer, a University of Houston T-cell expert is working to get consistent and durable patient responses by using the power of immunotherapy. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 5, 2018 Category: Cancer & Oncology Source Type: news

Cancer warning - does your head feel like this? ‘Unusual’ warning signs of brain tumours
CANCER symptoms vary depending on which part of the body is affected by a tumour. You could be at risk of deadly tumour signs if you often have this feeling in your head. (Source: Daily Express - Health)
Source: Daily Express - Health - November 5, 2018 Category: Consumer Health News Source Type: news

Public awareness of mouth cancer symptoms low, despite sharp rise in cases
Disease accounts for more than 8000 diagnoses and nearly 3000 deaths every year Related items fromOnMedica JCVI recommends universal HPV vaccination One or two doses of HPV jab may be enough Scotland launches its ‘Detect Cancer Early’ campaign Ditch habit for longer survival after head and neck cancer, smokers urged Obesity as cause of cancer set to overtake smoking (Source: OnMedica Latest News)
Source: OnMedica Latest News - November 5, 2018 Category: UK Health Source Type: news

Global Melanoma Deaths Up Among Men, But Not Women
(Source: Cancercompass News: Other Cancer)
Source: Cancercompass News: Other Cancer - November 5, 2018 Category: Cancer & Oncology Source Type: news

' Shared Decision-Making': Real or Just a Feel-Good Buzzword?
(MedPage Today) -- Patient gets PSA test without his knowledge, then told to report for prostate biopsy (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - November 4, 2018 Category: Hematology Source Type: news

Cancer symptoms warning: Six symptoms of the deadly disease to look out for
CANCER symptoms are varied and differ between different types of the disease, but spotting signs early can reduce the risk of the cancer spreading. These are six main symptoms of the disease to watch out for. (Source: Daily Express - Health)
Source: Daily Express - Health - November 4, 2018 Category: Consumer Health News Source Type: news

A cure for cancer: how to kill a killer
Revolutionary work on the body ’s immune system and a host of new drug trials mean that beating cancer may be achievableLast month, the Nobel prize in medicine was awarded fortwo breakthrough scientific discoveries heralded as having “revolutionised cancer treatment”, and “fundamentally changed the way we view how cancer can be managed”. One of them went to a charismatic, harmonica-playing Texan namedJim Allison for his breakthrough advances in cancer immunotherapy. His discovery had resulted in transformative outcomes for cancer patients and a radical new direction for cancer research.And yet...
Source: Guardian Unlimited Science - November 4, 2018 Category: Science Authors: Charles Graeber Tags: Cancer research Medical research Immunology Biochemistry and molecular biology Health Science Source Type: news

Why ponytails will no longer become wigs for the Canadian Cancer Society
Wigs made of real hair made life much better for many cancer patients. But advancements in wigs made from synthetic materials have led to a decline in the need for donated hair. (Source: CBC | Health)
Source: CBC | Health - November 4, 2018 Category: Consumer Health News Tags: News/Canada/Nova Scotia Source Type: news

Wormwood, most known for its use in absinthe, found to be highly beneficial in preventing liver cancer
(Natural News) Most people know wormwood as the key ingredient of absinthe, the controversial aperitif that, until recently, was banned in many countries (including the U.S.) because of its reported hallucinogenic effects. However, scientists from Inha University, Seoul National University, and Kyung Hee University in South Korea have found that Artemisia capillaris, one of the plants in the Artemesia genus known... (Source: NaturalNews.com)
Source: NaturalNews.com - November 4, 2018 Category: Consumer Health News Source Type: news

Men with prostate cancer willing to accept lower survival odds to avoid side effects
(National Cancer Research Institute) Men who have been newly diagnosed with prostate cancer say they would trade some improvement in their odds of survival for improvements in side effects and quality of life, according to research presented at the 2018 NCRI Cancer Conference. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 4, 2018 Category: International Medicine & Public Health Source Type: news

Patients with low risk thyroid cancer can receive lower doses of radiation treatment
(National Cancer Research Institute) Thyroid cancer patients whose disease is at low risk of returning can be treated safely with a smaller amount of radiation following surgery, according to results from the world's longest running trial to investigate this -- the HiLo trial. The research is presented at the 2018 NCRI Cancer Conference in Glasgow on Monday and means patients can enjoy a better quality of life without being at higher risk of their cancer returning. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 4, 2018 Category: International Medicine & Public Health Source Type: news

Melanoma death rates are rising in men but static or falling in women
(National Cancer Research Institute) The rate of men dying from malignant melanoma has risen in populations around the world, while in some countries the rates are steady or falling for women, according to research presented at the 2018 NCRI Cancer Conference. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 4, 2018 Category: Cancer & Oncology Source Type: news

Brain cancer: drink that makes tumours glow could make surgery more effective
Fluorescent marker accumulates in the fastest-growing cells, helping surgeons pinpoint tumours and leave healthy tissue aloneSurgeons have tested the use of a fluorescent marker that can help them remove dangerous brain tumour cells from patients more accurately.The research was carried out on people who had suspected glioblastoma,the disease that killed British politician Dame Tessa Jowell in May, and the most common form of brain cancer.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - November 4, 2018 Category: Science Authors: Press Association Tags: Cancer research Health Medical research Science Source Type: news

Glowing chemical 'could aid brain cancer surgery'
A chemical that makes brain tumours glow could help surgeons safely remove brain cancer, a study suggests. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - November 4, 2018 Category: Consumer Health News Source Type: news

Aurobindo recalls hypertensive drug in US citing cancer risk
ScieGen Pharmaceuticals has initiated recall of the finished Irbesartan drug from the market, a separate notification by the FDA said. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 4, 2018 Category: Pharmaceuticals Source Type: news

Cellphones And Cancer Risk: How To Use Your Cellphone More Safely
A National Toxicology Program (NTP) study found that the radiofrequency radiation from cell phones can cause cancer in rats, but here are the caveats. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - November 3, 2018 Category: Pharmaceuticals Authors: Bruce Y. Lee, Contributor Source Type: news

Morning Rounds: How Americans feel about cancer care
Cancer remains the nation's second leading cause of death. With so many touched by the illness, the American Society of Clinical Oncology conducted a survey on cancer-related issues. The group questioned nearly 5,000 Americans, including how optimistic people are about finding a cure for the disease within the next 50 years. Dr. David Agus joins “CBS This Morning: Saturday” to discuss the survey’s findings as well as a new editorial about regulating wearable devices that monitor our health. (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - November 3, 2018 Category: Consumer Health News Source Type: news

Cancer: Bupa launches male check service to detect prostate and testicular cancer symptoms
CANCER: Private healthcare firm Bupa has launched a new service to check for prostate and testicular cancer symptoms in men, following a big increase in male health assessment bookings. (Source: Daily Express - Health)
Source: Daily Express - Health - November 3, 2018 Category: Consumer Health News Source Type: news

Fluorescent marker can help guide surgeons to remove dangerous brain tumor cells more accurately
(National Cancer Research Institute) A chemical that highlights tumor cells has been used by surgeons to help spot and safely remove brain cancer in a trial presented at the 2018 NCRI Cancer Conference. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 3, 2018 Category: Cancer & Oncology Source Type: news

This Himalayan medicinal tree may be the key to novel anti-cancer and anti-diabetic treatments
(Natural News) Research has shown that the moru oak (Quercus dilatata), a tree found in the Himalayas, could be used to treat chronic diseases like cancer and diabetes, as well as prevent the spread of infectious diseases like leishmaniasis. The study, published in BMC Complementary and Alternative Medicine, determined the therapeutic effects of the tree, which has... (Source: NaturalNews.com)
Source: NaturalNews.com - November 3, 2018 Category: Consumer Health News Source Type: news

Illumina Shows That Big Medtech Deals Are Far from Over
Just when it looked like the year would end without another mega-merger, Illumina has swooped in to acquire its rival, Pacific Biosciences (PacBio), for $1.2 billion. The move would solidify San Diego, CA-based Illumina’s position in the genetic sequencing market. The acquisition is expected to close in mid-2019. Under the deal, which has been approved by both firms’ boards, Illumina would buy Menlo Park, CA-based PacBio at a price of $8 a share. This price represents a premium of 71% to Pacific Biosciences’ 30 trading day volume weighted average share price as of the m...
Source: MDDI - November 3, 2018 Category: Medical Devices Authors: Omar Ford Tags: Business Source Type: news

Twin radiation blasts that curb prostate cancer could prolong thousands of lives 
It simultaneously blasts the prostate with radiation from outside the body while using ‘tumour-seeking’ radio- active drugs internally. A trial has been tested on 28 men in Belfast. (Source: the Mail online | Health)
Source: the Mail online | Health - November 3, 2018 Category: Consumer Health News Source Type: news

Variation in Quality of Post-Surgery Cancer Care
A study of more than 350 hospitals found variations in readmission and mortality rates after cancer surgical procedures. (Source: CancerNetwork)
Source: CancerNetwork - November 3, 2018 Category: Cancer & Oncology Authors: Leah Lawrence Source Type: news

Age to Stop Cervical Cancer Screening Depends on Test Used
Negative HPV test, HPV - cytology co - test tied to low remaining lifetime cancer risk for unvaccinated (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - November 3, 2018 Category: Cancer & Oncology Tags: Family Medicine, Gynecology, Internal Medicine, Nursing, Oncology, Pathology, Journal, Source Type: news

Sign - Up Season Begins on HealthCare.gov
Insurers are expanding their participation in the program (Source: The Doctors Lounge - Psychiatry)
Source: The Doctors Lounge - Psychiatry - November 3, 2018 Category: Psychiatry Tags: Cardiology, Dermatology, Endocrinology, Family Medicine, Geriatrics, Gastroenterology, Gynecology, Infections, AIDS, Internal Medicine, Allergy, Critical Care, Emergency Medicine, Nephrology, Neurology, Nursing, Oncology, Ophthalmology, Orthopedics, ENT, Source Type: news

Novartis abandons effort for U.S. approval of biosimilar rituximab
Novartis International AG said on Friday that its Sandoz division is abandoning an effort to gain U.S. regulatory approval for a biosimilar of rituximab, a medication used to treat certain cancer and rheumatoid arthritis. (Source: Reuters: Health)
Source: Reuters: Health - November 2, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

FDA Approves Lorbrena (lorlatinib) for Previously-Treated ALK-Positive Metastatic Non-Small Cell Lung Cancer
November 2, 2018 Pfizer Inc. (NYSE:PFE) today announced that the U.S. Food and Drug Administration (FDA) has approved Lorbrena [lor-BREN-ah] (lorlatinib), a third-generation anaplastic lymphoma kinase (ALK) tyrosine kinase inhibitor (TKI) for... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - November 2, 2018 Category: Drugs & Pharmacology Source Type: news

FDA approves Pfizer's treatment for certain lung cancer patients
Pfizer Inc said on Friday the U.S. Food and Drug Administration has approved its lung-cancer treatment for patients with a specific gene mutation who had been previously treated for an aggressive form of the disease. (Source: Reuters: Health)
Source: Reuters: Health - November 2, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Blood Pressure Medication Recall: What Is In This That May Cause Cancer?
The FDA announced that Sciegen Pharmaceuticals, Inc. is voluntarily recalling irbesartan tablets. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - November 2, 2018 Category: Pharmaceuticals Authors: Bruce Y. Lee, Contributor Source Type: news

Remembering, Honoring and Celebrating the Life of Gail Purtan
(Source: Karmanos Cancer Institute)
Source: Karmanos Cancer Institute - November 2, 2018 Category: Cancer & Oncology Source Type: news

Age to Stop Cervical Cancer Screening Depends on Test Used
FRIDAY, Nov. 2, 2018 -- Continuing regular cytology screening up to age 75 years or performing an exit human papillomavirus (HPV) test to confirm the absence of oncogenic HPV strains past the age of 55 years offers preventive benefit for older women... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 2, 2018 Category: Pharmaceuticals Source Type: news

Cancer Fears Over Cell Phones, Again, but FDA Disagrees Cancer Fears Over Cell Phones, Again, but FDA Disagrees
The FDA steps in after a National Toxicology Program claim of'clear evidence'of link between high exposure to radio frequency radiation used in cell phones and cancer sparks a flurry of media reports.Medscape Medical News (Source: Medscape Med Students Headlines)
Source: Medscape Med Students Headlines - November 2, 2018 Category: Universities & Medical Training Tags: Hematology-Oncology News Source Type: news

Head and Neck Cancer Survivors Have Increased Suicide Risk
Survivors of head, neck cancers almost twice as likely to die from suicide as survivors of other cancers (Source: The Doctors Lounge - Psychiatry)
Source: The Doctors Lounge - Psychiatry - November 2, 2018 Category: Psychiatry Tags: Oncology, ENT, Psychiatry, Journal, Source Type: news